MedTrace Logo

WorkWell - Preventing Prescription Opioid Misuse Among Employees Working in High Risk Industries

NCT07799766 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 759

Last updated 2026-09-02

No results posted yet for this study

Summary

WorkWell is a mobile-delivered behavioral intervention designed to prevent prescription opioid misuse and overuse among construction workers and healthcare workers. Two sequential randomized factorial optimization trials evaluated intervention lessons targeting opioid-related beliefs, norms, pain-management alternatives, and patient-provider communication. Participants completed assessments at baseline, immediately after the intervention, and approximately 30 days later.

Conditions

  • Opioids

Interventions

BEHAVIORAL

WorkWell

Mobile-delivered behavioral intervention designed to prevent prescription opioid misuse and overuse among construction workers and nurses. WorkWell includes lessons addressing opioid-related knowledge, expectancies, norms, pain management alternatives, and patient-provider communication.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Prevention Strategies, LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-07
Primary Completion
2026-01-05
Completion
2026-01-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07799766 on ClinicalTrials.gov